Lafayette General Medical Center is a clinical research site located in Lafayette, Louisiana, United States 70503.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
Lafayette General Medical Center has participated in 9 clinical trials.
Therapeutic areas: Metastatic gpNMB Over-expressing Triple Negative Breast Cancer, Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Colitis, Ulcerative.
Sponsors: Celldex Therapeutics, Pfizer, Takeda.
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Lafayette General Medical Center has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lafayette General Medical Center has 9 clinical trials on record. Their work covers Metastatic gpNMB Over-expressing Triple Negative Breast Cancer, Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Colitis, Ulcerative.
Yes — Lafayette General Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.